From October 1, 2022 to December 31, 2022, the company has repurchased 115,419 shares, representing 1.38% for $0.46 million. With this, the company has completed the repurchase of 137,526 shares, representing 1.64% for $0.66 million under the buyback announced on August 16, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.251 USD | -0.17% | +2.79% | -29.21% |
04/06 | Lumos Pharma, Inc. Announces New Analyses of Phase 2 OraGrowtH212 Trial Presented at ENDO 2024 | CI |
15/05 | Lumos Pharma Announces Positive End-of-Phase 2 Meeting with FDA | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.21% | 1.83Cr | |
+38.71% | 3.91TCr | |
-8.05% | 3.88TCr | |
+29.04% | 3.12TCr | |
+10.65% | 2.59TCr | |
-13.75% | 2.58TCr | |
+44.13% | 1.41TCr | |
+38.43% | 1.31TCr | |
-6.92% | 1.13TCr | |
-12.29% | 1.07TCr |
- Stock Market
- Equities
- LUMO Stock
- News Lumos Pharma, Inc.
- Tranche Update on Lumos Pharma, Inc.'s Equity Buyback Plan announced on August 16, 2022.